Aldesleukin Recruiting Phase 0 Trials for Metastatic Non-Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT03224871UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.